home / stock / ntrb / ntrb short
Short Information | Nutriband Inc. (OTCMKTS:NTRB)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 20,081 |
Total Actual Volume | 33,856 |
Short Trends | |
---|---|
Cover Days | 5 |
Short Days | 12 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 1,004 |
Average Short Percentage | 59.12% |
Is there a NTRB Short Squeeze or Breakout about to happen?
See the NTRB Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
09-30-2021 | $8.35 | $8.75 | $11 | $8.35 | 2,251 | 736 | 32.7% |
09-29-2021 | $9.25 | $9.575 | $9.75 | $8.5 | 2,194 | 1,771 | 80.72% |
09-28-2021 | $9 | $8.75 | $9 | $8.25 | 3,746 | 1,934 | 51.63% |
09-27-2021 | $7.28 | $6.5 | $7.28 | $6.5 | 919 | 404 | 43.96% |
09-23-2021 | $7.7 | $5.76 | $7.7 | $5.76 | 4,443 | 2,114 | 47.58% |
09-21-2021 | $9 | $9 | $9 | $9 | 600 | 600 | 100% |
09-20-2021 | $9.02 | $8.75 | $9.16 | $8.75 | 3,511 | 2,628 | 74.85% |
09-17-2021 | $9 | $9.0125 | $10.25 | $9 | 1,205 | 1,007 | 83.57% |
09-16-2021 | $9.5 | $9 | $10.4 | $8.02 | 1,915 | 1,589 | 82.98% |
09-09-2021 | $12.3 | $13.6 | $15 | $12.3 | 4,174 | 2,559 | 61.31% |
09-08-2021 | $11 | $11.2 | $11.2 | $11 | 1,276 | 1,025 | 80.33% |
09-07-2021 | $10 | $10.4 | $10.4 | $10 | 1,161 | 290 | 24.98% |
07-28-2021 | $10.5 | $9 | $10.5 | $8.75 | 866 | 100 | 11.55% |
07-23-2021 | $10.5 | $10 | $10.5 | $10 | 1,100 | 1,100 | 100% |
07-08-2021 | $11.75 | $11.5 | $11.75 | $11 | 924 | 924 | 100% |
07-01-2021 | $11.55 | $11 | $11.55 | $11 | 573 | 100 | 17.45% |
06-30-2021 | $10.59 | $12.55 | $12.55 | $10.59 | 475 | 100 | 21.05% |
06-28-2021 | $13 | $13 | $13 | $13 | 122 | 100 | 81.97% |
06-18-2021 | $12.2 | $13 | $13 | $8 | 1,401 | 500 | 35.69% |
06-15-2021 | $12 | $15 | $15 | $12 | 1,000 | 500 | 50% |
News, Short Squeeze, Breakout and More Instantly...
150+ Americans die every day from synthetic opioid (e.g. fentanyl) overdose Nutriband’s AVERSA(TM) Fentanyl technology is being developed as an innovative solution to abuse and misuse rates in prescription opioid patch medications Nutriband raised $8.4 million in a private placement to...
Enact Holdings Inc. (ACT) is expected to report $0.99 for Q1 2024 FormFactor Inc. (FORM) is expected to report $0.09 for Q1 2024 SAAB AB - Class B (SAABF) is expected to report for quarter end 2024-03-31 Lumos Pharma Inc. (LUMO) is expected to report $-1.21 for Q1 2024 Axis Capita...